How to Design Greener Products Without Compromising Safety and Efficacy Introduction to Sustainability in Pharmaceutical Development The pharmaceutical industry faces increasing scrutiny regarding its environmental impact, making it essential for professionals to consider sustainability in product design. Understanding the life cycle assessment (LCA) and environmental risk assessment (ERA) requirements is critical in achieving this balance. Pharmaceutical products, including active pharmaceutical ingredients (APIs), can significantly affect the environment, particularly when evaluating their entire life cycle from cradle to grave. In this guide, we will explore the regulatory frameworks, methods for assessing environmental impact, and strategies for sustainable product development. Understanding Life…

ERA expectations in EU submissions and their relevance for US programs ERA expectations in EU submissions and their relevance for US programs Introduction to Life Cycle Assessment (LCA) and Environmental Risk Assessment (ERA) The pharmaceutical industry is increasingly recognizing the importance of sustainability in its operations. Life Cycle Assessment (LCA) and Environmental Risk Assessment (ERA) are two critical methodologies used to evaluate the environmental impacts and risks associated with pharmaceutical products, including active pharmaceutical ingredients (APIs). As regulatory authorities like the US FDA and the European Medicines Agency (EMA) emphasize sustainability, it becomes essential for pharmaceutical professionals to understand the…

Building a Multi-Year Roadmap for LCA and ERA Maturity in Your Company In recent years, the pharmaceutical industry has seen a growing emphasis on sustainability, particularly concerning the environmental impact of products and processes. As such, Life Cycle Assessment (LCA) and Environmental Risk Assessment (ERA) have become critical components in the lifecycle management of pharmaceuticals. This guide aims to provide a comprehensive step-by-step tutorial on building a multi-year roadmap for LCA and ERA maturity within your organization, ensuring regulatory compliance with U.S. FDA guidelines as well as consideration for UK and EU frameworks where applicable. Understanding Life Cycle Assessment (LCA)…

Future regulations that may mandate LCAs or ERAs for pharma products Future Regulations That May Mandate LCAs or ERAs for Pharma Products The pharmaceutical industry is undergoing a paradigm shift driven by increasing regulatory scrutiny and an enhanced focus on sustainability. This article provides a detailed, step-by-step tutorial on the potential future regulations that may require Life Cycle Assessments (LCAs) or Environmental Risk Assessments (ERAs) for pharmaceutical products. The intent is to equip pharma professionals — including those working in clinical operations, regulatory affairs, and medical affairs — with the necessary knowledge to prepare for these evolving requirements. Understanding Life…

Incorporating Patient Use-Phase Emissions into Holistic LCAs In the increasingly complex landscape of pharmaceutical manufacturing and environmental compliance, Life Cycle Assessment (LCA) emerges as a critical tool. This comprehensive process evaluates the environmental impact of a product from its inception to its disposal, commonly characterized as a “cradle-to-grave” approach. As the industry pivots towards sustainability, it is imperative for professionals involved in regulatory affairs, clinical operations, and medical affairs to aptly incorporate patient use-phase emissions into their LCAs to ensure conformity with U.S. Food and Drug Administration (FDA) expectations and to mitigate environmental risks effectively. Understanding Life Cycle Assessment (LCA)…

Digitalisation and Automation of LCA Workflows in Large Portfolios In response to increasing regulatory scrutiny and consumer demand for sustainable practices, pharmaceutical companies are increasingly focusing on life cycle assessment (LCA) and environmental risk assessment (ERA) for their products. Given the complex landscape of regulations enforced by the FDA and other organizations, this step-by-step tutorial will provide a comprehensive guide to digitalising and automating LCA workflows within large pharmaceutical portfolios. Understanding Life Cycle Assessment (LCA) and Environmental Risk Assessment (ERA) Life Cycle Assessment (LCA) is a systematic analysis aimed at assessing the environmental impacts of a product throughout its entire…

Training scientists and regulatory teams on LCA and ERA concepts Training Scientists and Regulatory Teams on LCA and ERA Concepts In the evolving landscape of pharmaceutical manufacturing and regulatory compliance, the integration of sustainability practices has become essential. Life Cycle Assessment (LCA) and Environmental Risk Assessment (ERA) are foundational tools that aid in understanding the environmental impacts of pharmaceutical products throughout their lifecycle. This tutorial is designed to guide pharma professionals, including those in clinical operations, regulatory affairs, and medical affairs, in mastering LCA and ERA concepts while ensuring compliance with FDA regulations. Understanding Life Cycle Assessment (LCA) Life Cycle…

Life Cycle Assessment LCA Fundamentals for Pharmaceutical Products Life Cycle Assessment LCA Fundamentals for Pharmaceutical Products In the rapidly evolving landscape of the pharmaceutical industry, sustainability has become a pivotal focus, not just for environmental responsibility but also for regulatory compliance and market competitiveness. Life Cycle Assessment (LCA) is a critical tool for evaluating the environmental impacts associated with all the stages of a product’s life, from cradle to grave. This article provides a comprehensive step-by-step tutorial on the fundamentals of LCA for pharmaceutical products, focusing on key regulatory requirements and industry practices in accordance with U.S. FDA expectations. Understanding…

Using Life Cycle Assessments to Prioritize Sustainability Projects Across Product Portfolios In the contemporary regulatory landscape, pharmaceutical companies face increasing pressures to enhance sustainability initiatives while remaining compliant with stringent U.S. FDA regulations. The integration of Life Cycle Assessment (LCA) methodologies into environmental risk assessments (ERA) has emerged as a pivotal strategy for both effectively managing pharma products and meeting sustainability objectives. This tutorial outlines the procedures for utilizing LCAs to prioritize sustainability projects within pharmaceutical product portfolios, emphasizing compliance with relevant FDA guidance and regulations. Understanding Life Cycle Assessment (LCA) Before diving into the application of LCA in sustainability…

How to run an LCA for a tablet, injectable or biologic from cradle to grave How to run an LCA for a tablet, injectable or biologic from cradle to grave The pharmaceutical industry is undergoing significant transformation aimed at enhancing sustainability, achieving net-zero emissions, and complying with environmental regulations. This tutorial provides a comprehensive, step-by-step approach to conducting a Life Cycle Assessment (LCA) for various pharmaceutical products, including tablets, injectables, and biologics. It aligns with the standards set forth by the US FDA and considers regulatory requirements in the UK and EU where applicable. Understanding Life Cycle Assessment (LCA) Life…